Precision immunotherapy is a crucial approach to improve the efficacy of anti-cancer treatments, particularly in the metastatic setting. In this respect, accurate patient selection takes advantage of the multidimensional integration of patients' clinical information and tumourspecific biomarkers status. Among these biomarkers, programmed death-ligand 1, tumour-infiltrating lymphocytes, microsatellite instability, mismatch repair and tumour mutational burden have been widely investigated. However, novel tumour-specific biomarkers and testing methods will further improve patients' outcomes. Here, we discuss the currently available strategies for the implementation of a precision immunotherapy approach in the clinical management of metastatic solid tumours and highlight future perspectives.
Biomarkers for precision immunotherapy in the metastatic setting : hope or reality? / E. Sajjadi, K. Venetis, C. Scatena, N. Fusco. - In: ECANCERMEDICALSCIENCE. - ISSN 1754-6605. - 14(2020), pp. 1150.1-1150.24. [10.3332/ecancer.2020.1150]
Biomarkers for precision immunotherapy in the metastatic setting : hope or reality?
E. SajjadiPrimo
;K. Venetis;N. Fusco
Ultimo
2020
Abstract
Precision immunotherapy is a crucial approach to improve the efficacy of anti-cancer treatments, particularly in the metastatic setting. In this respect, accurate patient selection takes advantage of the multidimensional integration of patients' clinical information and tumourspecific biomarkers status. Among these biomarkers, programmed death-ligand 1, tumour-infiltrating lymphocytes, microsatellite instability, mismatch repair and tumour mutational burden have been widely investigated. However, novel tumour-specific biomarkers and testing methods will further improve patients' outcomes. Here, we discuss the currently available strategies for the implementation of a precision immunotherapy approach in the clinical management of metastatic solid tumours and highlight future perspectives.File | Dimensione | Formato | |
---|---|---|---|
[2020] ecancermedicalscience-2020-article-1150.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Dimensione
5.33 MB
Formato
Adobe PDF
|
5.33 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.